Treatment with a GSK-3β/HDAC Dual Inhibitor Restores Neuronal Survival and Maturation in an In Vitro and In Vivo Model of CDKL5 Deficiency Disorder

Mutations in the X-linked cyclin-dependent kinase-like 5 (CDKL5) gene cause a rare neurodevelopmental disorder characterized by early-onset seizures and severe cognitive, motor, and visual impairments. To date there are no therapies for CDKL5 deficiency disorder (CDD). In view of the severity of the...

Descripción completa

Detalles Bibliográficos
Autores principales: Loi, Manuela, Gennaccaro, Laura, Fuchs, Claudia, Trazzi, Stefania, Medici, Giorgio, Galvani, Giuseppe, Mottolese, Nicola, Tassinari, Marianna, Rimondini Giorgini, Roberto, Milelli, Andrea, Ciani, Elisabetta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8198396/
https://www.ncbi.nlm.nih.gov/pubmed/34073043
http://dx.doi.org/10.3390/ijms22115950

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8198396/
https://www.ncbi.nlm.nih.gov/pubmed/34073043
http://dx.doi.org/10.3390/ijms22115950

Ejemplares similares